Haemonetics Corporation’s HAE impressive Hospital business recovery is poised to drive growth in the upcoming quarters. The robust uptake of the NexSys PCS system bodes well for its long-term growth.
Needham analyst Michael Matson maintained a Buy rating on Haemonetics (HAE – Research Report) today and set a price target of $104.00. The ...
AlphaQuest LLC boosted its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 36,520.0% in the fourth quarter, ...
Adnan Syed was formally re-sentenced on Friday, March 14, just over a week after a judge ruled he should not serve any more ...
Needham analyst Mike Matson lowered the firm’s price target on Haemonetics (HAE) to $104 from $108 and keeps a Buy rating on the shares. The ...
Adnan Syed has been resentenced for the 1999 murder of Hae Min Lee, a case that gained national attention after being ...
Research analysts at Zacks Research lowered their FY2025 EPS estimates for shares of Haemonetics in a report released on ...
The original manhwa shows Jinwoo and Cha Hae-In for the last time, and we are here to discuss where Suho's mother is in Solo ...